Press release
Inactivated Vaccine Market Is Growing Rapidly To Collect Huge Revenues For Market Leaders Pfizer Inc.,GlaxoSmithKline Plc, Seqirus, Valneva SE, Merck & Co., Inc.
Inactivated Vaccine
Download PDF Brochure of Reserach Report : https://www.coherentmarketinsights.com/insight/request-pdf/1905
Inactivated vaccines are on the U.S. Recommended Childhood Immunization Schedule, which includes the seasonal influenza vaccine and inactivated polio vaccine. Less immunogenicity of older vaccines are propelling demand for newly developed innovative vaccines with better efficacy. Researchers and market players are investing in R&D for the development of safe and effective vaccines, thereby boosting growth of the inactivated vaccines market.
"Inactivated Vaccine Market – Dynamics"
Introduction of new inactivated vaccines after completion of clinical studies are expected to boost growth of the inactivated vaccines market over the forecast period. For instance, in 2017, Merck’s investigational inactivated varicella zoster virus vaccine (V212) showed a decrease in the incidence of herpes zoster case by an estimated 64% in immunocompromised subjects in the first phase 3 trial. Clinical studies also revealed that V212 lessens the incidence of herpes zoster pain by around 69.5%. Moreover, V212 demonstrated 83.7% reduction in the incidence of post herpetic neuralgia. Rising prevalence of various viral and bacterial diseases around the globe have increased the demand for inactivated vaccines, which in turn will fuel the market growth. For instance, according to the World Health Organization (WHO) report in 2018, annual epidemics due to influenza were estimated to result in around 3 to 5 million cases of severe illness and around 290,000 to 650,000 deaths. Moreover, WHO 2018 report also showed that around 21 million cases and 222,000 typhoid-related deaths occur annually worldwide.
"Inactivated Vaccine Market – Competitive Analysis"
Major players operating in the global inactivated vaccine market include GlaxoSmithKline Plc, Seqirus, Valneva SE, Pfizer Inc., Merck & Co., Inc., Emergent BioSolutions, Bharat Biotech, and Sanofi. Major market players are involved in adopting market strategies such as mergers, acquisitions, partnership, collaborations, and development of new products with leading companies and research institutes, in order to retain dominant position in the market. For instance, in 2017, the U.S. Food and Drug Administration (FDA) approved GlaxoSmithKline Plc’s Shingrix, a zoster vaccine recombinant for the prevention of shingles in adults above the age of 50 years. Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses.
Request for Customization of Reserach Report: https://www.coherentmarketinsights.com/insight/request-customization/1905
"Inactivated Vaccine Market – Taxonomy"
On the basis of method of inactivation, the global inactivated vaccine market is segmented into:
- Solvent Detergent Method
- Radiation Method
- pH Concentration
- Heat Inactivation
- Others
On the basis of route of administration, the global inactivated vaccine market is segmented into:
- Oral
- Subcutaneous
- Intravenous
- Others
On the basis of geography, the global inactivated vaccine market is segmented into:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inactivated Vaccine Market Is Growing Rapidly To Collect Huge Revenues For Market Leaders Pfizer Inc.,GlaxoSmithKline Plc, Seqirus, Valneva SE, Merck & Co., Inc. here
News-ID: 1268093 • Views: …
More Releases from Coherent Market Insights - Biotechnology
Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled,"Wearable Patch Market, by Technology (Connected and Regular), by Application (Monitoring, Drug Delivery, and Diagnostics), by End User (Healthcare and Fitness & Sports), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027."
Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial…
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used…
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness…
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies.
Free Request Sample Copy…
More Releases for Inactivated
Global Inactivated Vaccine Market - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Inactivated Vaccine Market is projected to grow at a CAGR value of 10.5% from 2022 to 2027.
Growing health consciousness and government efforts to support vaccination, technological developments and infrastructure upgrades in the healthcare system, increased emphasis on research studies, and cooperation among various top research facilities in the domain to find a new methodology to…
Global Hepatitis A Vaccine, Inactivated Market Research Report
This report studies the global Hepatitis A Vaccine, Inactivated market status and forecast, categorizes the global Hepatitis A Vaccine, Inactivated market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report GlaxoSmithKline Merck Sanofi Berna Biotech Norvatis Sinovac Geographically, this report studies the top…
Inactivated Vaccine Market - Size, Share, Outlook, and Forecast till 2026
A vaccine that consists of virus particles, bacteria or other pathogens, which were grown in culture and then killed using heat or formaldehyde is called as inactivated vaccine or killed vaccine. The infectivity is reduced, as pathogens for inactivated vaccines are grown under controlled conditions and are killed. Inactivated vaccines are classified into whole virus vaccines, split virus vaccines, and subunit vaccines based on the method of inactivation of virus.
Get…
Inactivated Vaccine Market: Drivers, Regional Analysis, and Competitive Landscap …
A biological preparation that is used to provide active acquired immunity to a particular disease are called as vaccines. Vaccines are commonly of four types: live-attenuated vaccines, toxoid vaccines, subunit vaccines, and inactivated vaccines. Inactivated vaccines are created by inactivating a virus, bacteria or pathogens with the treatment of chemical (formaldehyde) or heat. These pathogens are grown in controlled culture condition and are killed to reduce their infectivity. Inactivated vaccines…
Inactivated Vaccines Market Size will Observe Substantial Growth by 2025
A biological preparation that enhances or provides acquired immunity to a certain disease is known as vaccine. A vaccine contains an agent that resembles the disease-causing organism either in a weakened form (known as live attenuated vaccine), or in a killed form of the microbe or its protein (known as inactivated vaccine). Body’s immune system is stimulated by the agent, which is recognized as a foreign body by this immune…
Inactivated Vaccines Market Foraying into Emerging Economies During 2017 - 2025
A biological preparation that enhances or provides acquired immunity to a certain disease is known as vaccine. A vaccine contains an agent that resembles the disease-causing organism either in a weakened form (known as live attenuated vaccine), or in a killed form of the microbe or its protein (known as inactivated vaccine). Body’s immune system is stimulated by the agent, which is recognized as a foreign body by this immune…
